Radboud University Nijmegen Medical Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

    ESMO Open, Vol. 9, Núm. 6